Abstract:Objective Lectin-like Ox-LDL receptor-1 (LOX-1), a novel vascular receptor for oxidized LDL, is responsible for recognition and internalization of ox-LDL in vascular cells. It also mediates a spectrum of pro-atherogenic cellular responses implicated in the development and progression of atherosclerosis including endothelial dysfunction and apoptosis, vascular inflammation, foam cell formation and collagen deposition. Previous studies revealed that expression of LOX-1 was highly inducible by proinflammatory stimuli, such as tumor necrosis factor-alpha (TNF-α), Ox-LDL and lipopolysaccharide (LPS). We have demonstrated that tanshinone II-A (a diterpene flavonoids isolated from Tanshen) supplementation retarded the atherogenesis progression in ApoE knockout mice via inhibition of LOX-1 expression. Therefore, we hypothesized that tanshinone II-A could also inhibit LOX-1 expression induced by pro-inflammatory stimuli in murine macrophages. Design and Methods RAW264.7 cells and murine peritoneal macrophages were cultured. Quantitative real-time PCR and western blot were used to determine LOX-1 gene and protein expression. Electrophoretic mobility shift assay (EMSA) was performed to demonstrate the nuclear protein binding to NF-κB regulatory element of LOX-1 gene. Results Pretreatment of cultured macrophages with tanshinone II-A inhibited LOX-1 expression induced by Ox-LDL at both protein and mRNA levels in a time- and concentration-dependent manner. The inhibitory effect was also observed in the cells treated with antioxidants or inhibitors of nuclear factor-kappaB (NF-κB). The activation of NF-κB and phosphorylation of inhibitory factor of NF-kappaB-α (IκB-α) induced by Ox-LDL were suppressed by tanshinone II-A in a time- and concentration-dependent fashion. Ox-LDL also enhanced the binding of nuclear protein to NF-κB regulatory element of LOX-1 gene promoter. This effect was abrogated by tanshinone II-A. Furthermore, the DiI-Ox-LDL uptake study demonstrated that tanshinone II-A concentration-dependently diminished Ox-LDL uptake by macrophages. Conclusions Tanshinone II-A suppressed Ox-LDL-induced LOX-1 expression and the subsequent macrophage foam cell formation, by inhibiting NF-κB activation and ROS generation.

[Tyrosine Kinase Dependent Lectin-Like Oxidized LDL Receptor-1 Upregulation by Thrombin and Factor Xa in Vascular Smooth Muscle Cells].

Effects of Angiotensin II on Expression of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Cultured THP-1 Cells

[Value of Serum Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1) and LOX-1 Mrna in Peripheral Mononuclear Cells in Early Diagnosis of Acute Coronary Syndrome].

[Angiotensin II Increases the Expression of Lectin-Like Oxidize Low-Density Lipoprotein Receptor- 1 in Cultured Human Umbilical Vein Endothlial Cells]

Ox-LDL increases OX40L in endothelial cells through a LOX-1-dependent mechanism

Oxidized LDL but Not Angiotensin II Induces Cardiomyocyte Hypertrophic Responses Through the Interaction Between LOX-1 and AT1 Receptors

Role of Oxidized LDL Receptor in Endothelial Cellular Injury by Oxidized Low-Density Lipoprotein

Progress in Lecin-Like Oxidized LDL Receptor-1 As a Novel Therapeutic Target in Atherosclerotic Cardiovascular Diseases

LOX-1 in atherosclerosis: biological functions and pharmacological modifiers

Targeting LOX‐1 in Atherosclerosis and Vasculopathy: Current Knowledge and Future Perspectives

Oxidized low density lipoprotein stimulated endothelial nitric oxide by activating lectin-like oxidized-LDL receptor

Role of Ox-LDL and LOX-1 in Atherogenesis

Native and Oxidized Low-Density Lipoproteins Increase the Expression of the LDL Receptor and the LOX-1 Receptor, Respectively, in Arterial Endothelial Cells

Oxidized LDL but not angiotensin II induces the interaction between LOX-1 and AT1 receptors

Identification and Autoregulation of Receptor for OX-LDL in Cultured Human Coronary Artery Endothelial Cells

Lysyl oxidase (LOX) down-regulation by TNFalpha: a new mechanism underlying TNFalpha-induced endothelial dysfunction

Abstract 18189: Direct Binding of LOX-1 with AT1 Receptors Mediates Ox-LDL-Induced Cardiomyocyte Hypertrophy

Reactive Oxygen Species Mediate Oxidized Low-Density Lipoprotein-Induced Endothelin-1 Gene Expression Via Extracellular Signal-Regulated Kinase in Vascular Endothelial Cells

OxLDL enhances procoagulant activity of endothelial cells by TMEM16F‐mediated phosphatidylserine exposure

Overexpression of LOX-1 in hepatocytes protects vascular smooth muscle cells from phenotype transformation and wire injury induced carotid neoatherosclerosis through ALOX15

Tanshinone II-A Inhibited Oxidized Low-Density-Lipoprotein Induced LOX-1 Expression in Murine Macrophages by Reduction of Intracellular Reactive Oxygen Species (ROS) and NF-KappaB Activation